<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03619447</url>
  </required_header>
  <id_info>
    <org_study_id>ESP vs Serratus</org_study_id>
    <nct_id>NCT03619447</nct_id>
  </id_info>
  <brief_title>Comparison of ESP Block Versus Serratus Block</brief_title>
  <official_title>Comparison of the Ultrasound Guided Erector Spinae Plane Block Versus Serratus Plane Block in Totally Mastectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cukurova University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cukurova University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Total 60 patients, American society of anaesthesiology physical status I-II aged between
      18-65 who underwent totally mastectomy will recruit to the study. The patients randomly
      divided into two groups. Ultrasound guided Erector spinae plane block (ESP) will perform with
      15 ml bupivacaine+ 5 ml lidocaine in Group ESP and ultrasound guided serratus anterior plane
      (SAP) block will perform with 5 ml bupivacaine+ 5 ml lidocaine in Group SAP. Postoperative
      pain assessment will apply with 11-point numerical rating scale (NRS) and postoperative
      analgesic requirement will calculate and record with morphine consumption (patient controlled
      analgesia).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, total 60 patients, American society of anaesthesiology physical status I-II
      aged between 18-65 who underwent totally mastectomy will recruit. Using with computer
      randomisation, the patients allocate into two groups. Anaesthesia induction will perform with
      2 mg/kg propofol, 0.6 mg/kg rocuronium and 2 microgram/kg fentanil and general anaesthesia
      will maintain with sevoflurane %1-2 +%40-60 O2-N20 mixture and remifentanil infusion. All of
      the blocks will perform under general anaesthesia. Ultrasound guided Erector spinae plane
      block (ESP) will perform with 15 ml bupivacaine+ 5 ml lidocaine in Group ESP and ultrasound
      guided serratus anterior plane (SAP) block will perform with 5 ml bupivacaine+ 5 ml lidocaine
      in Group SAP. Postoperative pain, analgesic requirement and complications will evaluate.
      Postoperative pain assessment will apply with 11-point numerical rating scale (NRS) and
      postoperative analgesic requirement will calculate and record with morphine consumption
      (patient controlled analgesia).
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 15, 2018</start_date>
  <completion_date type="Anticipated">April 15, 2019</completion_date>
  <primary_completion_date type="Anticipated">March 15, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
    <masking_description>Both participants and anaesthesia provider will not know which intervention applied. Another anaesthesia provider who did not perform any block will follow and record to the study data.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>morphine consumption</measure>
    <time_frame>up to postoperative 24th hours.</time_frame>
    <description>Patient controlled analgesia (PCA) will provide with morphine PCA. Total morphine consumption will calculate and record till the postoperative 24th hours.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>numerical rating scale score</measure>
    <time_frame>up to postoperative 24th hours.</time_frame>
    <description>Postoperative pain assessment will apply with 11-point numerical rating scale. These scores will record till the postoperative 24 th hours.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>ESP block group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Under general anaesthesia, Ultrasound guided ESP block will perform at the T6 level with15 ml bupivacain+ 5ml lidocaine, bilaterally. Morphine 0.1 mg/kg will administer at last 30 minutes of surgery for postoperative analgesia. Patient controlled analgesia (PCA) with morphine will apply to the all patients. Postoperative pain assessment and morphine consumption will record till the postoperative 24 th hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>serratus block group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Under general anaesthesia, Ultrasound guided SAP block will perform at the T6 level with15 ml bupivacain+ 5ml lidocaine, bilaterally. Morphine 0.1 mg/kg will administer at last 30 minutes of surgery for postoperative analgesia. Patient controlled analgesia (PCA) with morphine will apply to the all patients. Postoperative pain assessment and morphine consumption will record till the postoperative 24 th hours.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ESP block group</intervention_name>
    <description>USG guided Erector spinae block (ESP) will perform bilaterally.</description>
    <arm_group_label>ESP block group</arm_group_label>
    <other_name>USG guided ESP block group</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>serratus block group</intervention_name>
    <description>USG guided serratus plane block will perform bilaterally</description>
    <arm_group_label>serratus block group</arm_group_label>
    <other_name>USG guided serratus plane block</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA I-II patients

          -  Being volunteer

          -  Total mastectomy

        Exclusion Criteria:

          -  ASA III and over

          -  Renal and hepatic failure

          -  Non Volunteers

          -  Emergency procedures
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ebru Biricik</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cukurova University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ebru Biricik</last_name>
    <phone>05052420223</phone>
    <email>ebrubiricik01@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Feride Karacaer</last_name>
    <phone>05062628416</phone>
    <email>feridekaracaer@gmail.com</email>
  </overall_contact_backup>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>August 2, 2018</study_first_submitted>
  <study_first_submitted_qc>August 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 7, 2018</study_first_posted>
  <last_update_submitted>August 6, 2018</last_update_submitted>
  <last_update_submitted_qc>August 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cukurova University</investigator_affiliation>
    <investigator_full_name>ebru biricik</investigator_full_name>
    <investigator_title>Anesthesiologist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

